Which term describes a set of structural features in a molecule that is recognized at a receptor site and is responsible for that molecule's pharmacological or biological activity?

Which term describes a set of structural features in a molecule that is recognized at a receptor site and is responsible for that molecule's pharmacological or biological activity?

• A. Receptor binding site arrangement
• B. A set of structural features in a molecule that is recognized at a receptor site and is responsible for that molecule's pharmacological or biological activity
• C. Pharmacodynamic model
• D. Enantiomeric purity

Answer: (B)

A pharmacophore is the set of essential structural features in a molecule that a receptor recognizes and that drive the molecule’s pharmacological or biological activity. This concept focuses on the features themselves (such as hydrogen bond donors/acceptors, hydrophobic regions, and charged groups) and how they’re arranged in three-dimensional space to fit the receptor’s binding site. The option given describes exactly this idea, making it the best choice. The other terms don’t fit as well. Receptor binding site arrangement would refer to the receptor’s own features and geometry, not the ligand’s essential features. A pharmacodynamic model describes how drug effect relates to concentration without detailing the specific ligand features needed for recognition. Enantiomeric purity concerns the proportion of chiral forms, not the set of features that determine receptor recognition and activity.

A pharmacophore is the set of essential structural features in a molecule that a receptor recognizes and that drive the molecule’s pharmacological or biological activity. This concept focuses on the features themselves (such as hydrogen bond donors/acceptors, hydrophobic regions, and charged groups) and how they’re arranged in three-dimensional space to fit the receptor’s binding site. The option given describes exactly this idea, making it the best choice.

The other terms don’t fit as well. Receptor binding site arrangement would refer to the receptor’s own features and geometry, not the ligand’s essential features. A pharmacodynamic model describes how drug effect relates to concentration without detailing the specific ligand features needed for recognition. Enantiomeric purity concerns the proportion of chiral forms, not the set of features that determine receptor recognition and activity.